Intriguingly, we found that CDK15 negatively modulates the cancer cell motility, as evidenced by the facts that overexpression of CDK15 in breast cancer cells significantly repressed their migration, invasion and metastasis; while knockdown of CDK15 in normal breast cells greatly enhanced the migratory and invasive capacity. Here, CDK15 is linked to breast cancer.